ResMed
RMD
225.98
+5.29
+2.40%
ResMed
US · RMD
#644 by market cap
Listed 1970
225.98
+5.29
+2.40%
Live - 5344 symbols - heartbeat 104s ago
· 2026-10-08 08:33
Pre-market
225.98
0.00%
After-hours
225.98
0.00%
Overnight
224.90
-0.48%
- Market cap
- 31.78B
- P/E (TTM)i
- 21.67
- P/Bi
- 4.83
- EPSi
- 10.43
- Div yieldi
- 1.06%
- 52W posi
- 48%
Reader sentiment
Are you bullish or bearish on RMD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.7 percentage points.
Institutional ownership
- Held by institutions
- 79.26% +0.71pp
- Institutions
- 1,152 -4
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund63.61%
Government Pension Fund6.67%
Public Company3.20%
Hedge Fund2.74%
Private Company1.74%
Individual/Insider0.52%
Sovereign Wealth Fund0.51%
Insurance Company0.29%
Family Office/Trust0.14%
Other20.58%
Top holders as of 2026-08-31
BlackRock
8.75% · 12.51M sh
Vanguard Capital Management, LLC
7.19% · 10.29M sh
Vanguard Portfolio Management, LLC
5.53% · 7.91M sh
State Street Global Advisors
4.79% · 6.86M sh
Australian Super
4.59% · 6.57M sh
Geode Capital Management, LLC
3.04% · 4.35M sh
Walter Scott & Partners Limited
1.84% · 2.63M sh
First Trust Advisors L.P.
1.59% · 2.28M sh
UBS Asset Management
1.50% · 2.15M sh
Invesco Capital Management LLC
1.28% · 1.83M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 21 buys · 29 sells
| Name | Role | Stake |
|---|---|---|
| Michael Farrell | Chairperson & CEO | 0.33% |
| Brett Sandercock | Chief Financial Officer | 0.06% |
| Peter Farrell | Founder, Chair Emeritus & Director | 0.04% |
| Justin Leong | President of Asia & Latin America | 0.02% |
| Ronald Taylor | Lead Independent Director | 0.02% |
| Richard Sulpizio | Independent Director | 0.01% |
| Carol Burt | Independent Director | 0.01% |
| Kaushik Ghoshal | President of SaaS Business | 0.01% |
| Harjit Gill | Independent Director | 0.01% |
| Karen Drexler | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-07 | Michael Farrell | Chairperson & CEO | Derivative Exercise and Sale | -4,991 | $146.34–222.44 |
| 2026-09-01 | Peter Farrell | Founder, Chair Emeritus & Director | Automatic Disposition | -970 | $234.73 |
| 2026-08-13 | Justin Leong | President of Asia & Latin America | Other Acquisition | +6,461 | -- |
| 2026-08-13 | Michael Farrell | Chairperson & CEO | Other Acquisition | +13,547 | -- |
| 2026-08-13 | Michael Rider | Global General Counsel & Secretary | Other Acquisition | +3,230 | -- |
| 2026-08-13 | Aaron Bloomer | Chief Financial Officer | Other Acquisition | +9,072 | -- |
| 2026-08-06 | Michael Farrell | Chairperson & CEO | Derivative Exercise and Sale | -4,991 | $146.34–205.69 |
| 2026-08-04 | Peter Farrell | Founder, Chair Emeritus & Director | Automatic Disposition | -8,000 | $225.00 |
| 2026-07-06 | Michael Farrell | Chairperson & CEO | Derivative Exercise and Sale | -4,991 | $146.34–218.55 |
| 2026-06-07 | Michael Farrell | Chairperson & CEO | Derivative Exercise and Sale | -4,991 | $146.34–193.96 |
| 2026-05-31 | Michael Rider | Global General Counsel & Secretary | Sale to Issuer | -268 | $190.57 |
| 2026-05-26 | Brett Sandercock | Chief Financial Officer | Intent to Sell (Form 144) | -8,000 | $209.07 |
| 2026-05-06 | Michael Farrell | Chairperson & CEO | Derivative Exercise and Sale | -4,991 | $146.34–207.82 |
| 2026-04-06 | Michael Farrell | Chairperson & CEO | Derivative Exercise and Sale | -4,991 | $146.34–225.50 |
| 2026-03-31 | Peter Farrell | Founder, Chair Emeritus & Director | Automatic Disposition | -2,000 | $225.00 |
| 2026-03-31 | Brett Sandercock | Chief Financial Officer | Automatic Disposition | -1,000 | $224.31 |
| 2026-03-08 | Michael Farrell | Chairperson & CEO | Derivative Exercise and Sale | -4,991 | $146.34–251.03 |
| 2026-03-03 | Peter Farrell | Founder, Chair Emeritus & Director | Automatic Disposition | -2,000 | $260.22 |
| 2026-03-01 | Brett Sandercock | Chief Financial Officer | Automatic Disposition | -1,000 | $254.30 |
| 2026-02-08 | Michael Farrell | Chairperson & CEO | Derivative Exercise and Sale | -4,991 | $146.34–273.78 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:33:46 · For reference only, not investment advice and not tailored to your situation.